Article
Gastroenterology & Hepatology
Emily W. Lopes, Simon S. M. Chan, Mingyang Song, Jonas F. Ludvigsson, Niclas Hakansson, Paul Lochhead, Allan Clark, Kristin E. Burke, Ashwin N. Ananthakrishnan, Amanda J. Cross, Domenico Palli, Manuela M. Bergmann, James M. Richter, Andrew T. Chan, Ola Olen, Alicja Wolk, Hamed Khalili
Summary: This study aimed to estimate the proportion of cases of Crohn's disease (CD) and ulcerative colitis (UC) that could be prevented by modifiable lifestyle factors. Using several cohorts in the US and Europe, the researchers created modifiable risk scores and healthy lifestyle scores, and found that a significant number of CD and UC cases could be prevented through lifestyle modification.
Article
Gastroenterology & Hepatology
Manasi Agrawal, Heidi S. Christensen, Martin Bogsted, Jean-Frederic Colombel, Tine Jess, Kristine H. Allin
Summary: The incidence and prevalence of IBD have increased in Denmark over the past two decades, and the IBD population is shifting towards an older age.
Article
Gastroenterology & Hepatology
Joyce Wing Yan Mak, Meng-Tzu Weng, Shu Chen Wei, Siew Chien Ng
Summary: The study found no cases of COVID-19 infection among IBD patients in Hong Kong and Taiwan. Most IBD patients in Hong Kong and Taiwan were on medication, with recommendations to continue their medication as prescribed during the pandemic.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
(2021)
Article
Medicine, General & Internal
Dominic King, Joht Singh Chandan, Tom Thomas, Alastair K. Denniston, Tasanee Braithwaite, Krishnarajah Niranthrankumar, Raoul Reulen, Nicola Adderley, Nigel J. Trudgill
Summary: This study evaluated the risk of subsequent inflammatory bowel diseases (IBD) in patients with ocular inflammation and found that patients with ocular inflammation have a twofold increased risk of IBD diagnosis.
Article
Gastroenterology & Hepatology
James D. Lewis, Lauren E. Parlett, Michele L. Jonsson Funk, Colleen Brensinger, Virginia Pate, Qufei Wu, Ghadeer K. Dawwas, Alexandra Weiss, Brad D. Constant, Maureen Mccauley, Kevin Haynes, Jeff Yufeng Yang, Douglas E. Schaubel, Andres Hurtado-Lorenzo, Michael David Kappelman
Summary: This study aimed to estimate the incidence, prevalence, and racial-ethnic distribution of physician-diagnosed inflammatory bowel disease (IBD) in the United States. Four administrative claims data sets were used, and corresponding estimates were obtained. The incidence of IBD remained relatively stable between the ages of 20 and 80, with variations in diagnosis rates among different races and ethnicities.
Article
Gastroenterology & Hepatology
Timothy R. Card, Eran Zittan, Geoffrey C. Nguyen, Matthew J. Grainge
Summary: The study aimed to assess the cardiovascular risk in patients with inflammatory bowel diseases, finding no overall excess of vascular events in the IBD group, but an increased risk of myocardial infarction with more active disease. This suggests the potential for anti-inflammatory therapies to reduce cardiovascular risk in IBD patients.
INFLAMMATORY BOWEL DISEASES
(2021)
Article
Medicine, General & Internal
Maria Chaparro, Ana Garre, Andrea Nunez Ortiz, Maria Teresa Diz-Lois Palomares, Cristina Rodriguez, Sabino Riestra, Milagros Vela, Jose Manuel Benitez, Estela Fernandez Salgado, Eugenia Sanchez Rodriguez, Vicent Hernandez, Rocio Ferreiro-Iglesias, Angel Ponferrada Diaz, Jesus Barrio, Jose Maria Huguet, Beatriz Sicilia, Maria Dolores Martin-Arranz, Xavier Calvet, Daniel Ginard, Inmaculada Alonso-Abreu, Luis Fernandez-Salazar, Pilar Varela Trastoy, Montserrat Rivero, Isabel Vera-Mendoza, Pablo Vega, Pablo Navarro, Monica Sierra, Jose Luis Cabriada, Mariam Aguas, Raquel Vicente, Merce Navarro-Llavat, Ana Echarri, Fernando Gomollon, Elena Guerra del Rio, Concepcion Pinero, Maria Jose Casanova, Katerina Spicakova, Jone Ortiz de Zarate, Emilio Torrella Cortes, Ana Gutierrez, Horacio Alonso-Galan, Alvaro Hernandez-Martinez, Jose Miguel Marrero, Rufo Lorente Poyatos, Margalida Calafat, Lidia Marti Romero, Pilar Robledo, Orencio Bosch, Nuria Jimenez, Maria Esteve Comas, Jose Maria Duque, Ana Maria Fuentes Coronel, Manuela Josefa Sampedro, Eva Sese Abizanda, Belen Herreros Martinez, Liliana Pozzati, Hipolito Fernandez Rosaenz, Belen Crespo Suarez, Pilar Lopez Serrano, Alfredo J. Lucendo, Margarita Munoz Vicente, Fernando Bermejo, Jose Joaquin Ramirez Palanca, Margarita Menacho, Amalia Carmona, Raquel Camargo, Sandra Torra Alsina, Nuria Maroto, Juan Nerin de la Puerta, Elena Castro, Ignacio Marin-Jimenez, Belen Botella, Amparo Sapina, Noelia Cruz, Jose Luis F. Forcelledo, Abdel Bouhmidi, Carlos Castano-Milla, Veronica Opio, Isabel Nicolas, Marcos Kutz, Alfredo Abraldes Bechiarelli, Jordi Gordillo, Yolanda Ber, Yolanda Torres Dominguez, Maria Teresa Novella Duran, Silvia Rodriguez Mondejar, Francisco J. Martinez-Cerezo, Lilyan Kolle, Miriam Sabat, Cesar Ledezma, Eduardo Iyo, Oscar Roncero, Rebeca Irisarri, Laia Lluis, Isabel Blazquez Gomez, Eva Maria Zapata, Maria Jose Alcala, Cristina Martinez Pascual, Maria Montealegre, Laura Mata, Ana Monrobel, Alejandro Hernandez Camba, Luis Hernandez, Maria Tejada, Alberto Mir, Maria Luisa Galve, Marta Soler, Daniel Hervias, Jose Antonio Gomez-Valero, Manuel Barreiro-de Acosta, Fernando Rodriguez-Artalejo, Esther Garcia-Esquinas, Javier P. Gisbert
Summary: The study found a high incidence of inflammatory bowel disease (IBD) in Spain, similar to that reported in Northern Europe. IBD patients require substantial therapeutic resources, especially in cases of Crohn's disease (CD) and in hospitals with high resources, which are much higher than previously reported.
JOURNAL OF CLINICAL MEDICINE
(2021)
Review
Nutrition & Dietetics
John Gubatan, Chiraag V. V. Kulkarni, Sarah Melissa Talamantes, Michelle Temby, Touran Fardeen, Sidhartha R. R. Sinha
Summary: Diet has a significant impact on intestinal immune homeostasis and the occurrence of inflammatory bowel disease (IBD). Studies have shown that ultra-processed foods, food additives, and emulsifiers are associated with a higher risk of IBD. While exclusion and elimination diets can improve symptoms, they do not affect objective markers of inflammation.
Article
Gastroenterology & Hepatology
Jakob Ronnow Sand, Frederikke Schonfeldt Troelsen, Erzsebet Horvath-Puho, Victor W. Henderson, Henrik Toft Sorensen, Rune Erichsen
Summary: Inflammatory bowel disease (IBD) is associated with a slightly increased risk of dementia, particularly frontotemporal dementia in patients with Crohn's disease (CD). Frequent healthcare system contacts by IBD patients may play a role in this association.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
(2022)
Review
Pediatrics
Stephen M. M. Borowitz
Summary: Inflammatory bowel disease (IBD) has been increasing globally over the past century and has spread to developing countries. Genetic factors and environmental exposures both contribute to the development of IBD. Urban areas and good domestic hygiene during childhood are associated with a higher risk of IBD. Migration from high to low incidence areas affects the risk of developing IBD. Early environmental exposures may trigger IBD in genetically susceptible individuals, but specific triggers remain unknown.
FRONTIERS IN PEDIATRICS
(2023)
Article
Gastroenterology & Hepatology
Adjoa Anyane-Yeboa, Maame Araba E. Buadu, Hamed Khalili, Yvette C. Cozier
Summary: This study investigated the epidemiology and disease characteristics of inflammatory bowel disease (IBD) in Black women, finding that the incidence of IBD was similar to that in White women. Future research should focus on identifying risk factors for IBD in Black individuals in the United States.
INFLAMMATORY BOWEL DISEASES
(2023)
Review
Gastroenterology & Hepatology
Manasi Agrawal, Tine Jess
Summary: The epidemiology of inflammatory bowel disease is undergoing changes, with rising incidence and burden of disease. Understanding the causes and preparing healthcare systems are crucial for improving outcomes and health.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL
(2022)
Article
Gastroenterology & Hepatology
Mads Damsgaard Wewer, Ebbe Langholz, Pia Munkholm, Flemming Bendtsen, Jakob Benedict Seidelin, Johan Burisch
Summary: This study describes the disease patterns and long-term outcomes in patients with inflammatory bowel disease (IBD). It found that patients with quiescent Crohn's disease (CD) and those with chronic continuous or increasing activity ulcerative colitis (UC) had an increased risk of developing intestinal cancer.
JOURNAL OF CROHNS & COLITIS
(2023)
Article
Gastroenterology & Hepatology
Frederikke S. Troelsen, Henrik T. Sorensen, Seth D. Crockett, Lars Pedersen, Rune Erichsen
Summary: In patients with inflammatory bowel disease (IBD), postcolonoscopy colorectal cancers (PCCRC) account for 50% of cases and have distinct characteristics, while the survival rates are similar to those of colorectal cancer (dCRC) with immediate diagnosis after colonoscopy.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
(2022)
Article
Medicine, General & Internal
Jesus K. Yamamoto-Furusho, Norma N. Parra-Holguin, Fabian Juliao-Banos, Fabian Puentes, Rocio Lopez, Francisco Bosques-Padilla, Esther A. Torres, Humberto Nieves-Jimenez, Guillermo R. Veitia-Velasquez, Maria L. Jara-Alba, Socrates Bautista, Felipe N. Pinol-Jimenez, Pablo Salgado-Rosado, Keyla C. Villa-Ovalles, Yudelka A. Abreu-Martinez, Zunilda Borges, Santiago Davila-Bedoya, Guillermo Otoya-Moreno, Beatriz Iade-Vergara
Summary: This study in Latin America and the Caribbean described the epidemiological and clinical characteristics of IBD in several countries, showing differences in CD and UC prevalence among countries, with patients from the Caribbean exhibiting unique clinical features.